RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Thursday for Catalyst Biosciences
(Updated on Dec 14, 2023)

Buy or Hold candidate since Oct 25, 2023 Loss -3.53% PDF

No changes to the price of Catalyst Biosciences stock on the last trading day (Thursday, 14th Dec 2023). During the last trading day the stock fluctuated 0% from a day low at $0.511 to a day high of $0.511. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.27% during the next 3 months and, with a 90% probability hold a price between $0.399 and $0.643 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CBIO Signals & Forecast

There are mixed signals in the stock today. The Catalyst Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.511 and $0.512. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, October 30, 2023, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Catalyst Biosciences stock

Catalyst Biosciences finds support from accumulated volume at $0.500 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.481 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 32 days ago.)

Trading Expectations (CBIO) For The Upcoming Trading Day Of Friday 15th

For the upcoming trading day on Friday, 15th we expect Catalyst Biosciences to open at $0.511, and during the day (based on 14 day Average True Range), to move between $0.506 and $0.517, which gives a possible trading interval of +/-$0.0057 (+/-1.12%) up or down from last closing price. If Catalyst Biosciences takes out the full calculated possible swing range there will be an estimated 2.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.500 (2.21%) than the resistance at $0.530 (3.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Catalyst Biosciences stock A Buy?

Catalyst Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Catalyst Biosciences of Friday, December 15, 2023

Fair opening price December 15, 2023 Current price
$0.511 ( 0%) $0.511

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CBIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.511 .
R2 0.511 .
R1 0.511 .
Current price: 0.511
Support S1 0.511 .
S2 0.511 .
S3 0.511 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.550 7.57 %
R2 0.539 5.42 %
R1 0.530 3.66 %
Current price 0.511
Support S1 0.500 -2.21%
S2 0.431 -15.67%
S3 0.420 -17.86%

CBIO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 04, 2023 Jan 13, 2023 Jan 12, 2023 $0.240 38.10%
2 Aug 25, 2022 Sep 21, 2022 Sep 20, 2022 $1.43 73.71%
3 Aug 04, 2015 Aug 20, 2015 Aug 19, 2015 $59.74 25.75%

FAQ

What is the symbol for Catalyst Biosciences Stock and on which exchange is it traded?
The symbol for Catalyst Biosciences is CBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Biosciences Stock?
Catalyst Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Catalyst Biosciences Stock?
Catalyst Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Biosciences Stock.

What's the current price of Catalyst Biosciences Stock?
As of the end of day on the 2023-12-14, the price of an Catalyst Biosciences (CBIO) share was $0.511.

What is the 52-week high and low for Catalyst Biosciences Stock?
The 52-week high for Catalyst Biosciences Stock is $0.739 and the 52-week low is $0.189.

What is the market capitalization of Catalyst Biosciences Stock?
As of the 2023-12-14, the market capitalization of Catalyst Biosciences is 19.418M.
Click to get the best stock tips daily for free!

About Catalyst Biosciences

Catalyst Biosciences Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT